Wound Care (Pharmacies) - Brunei Darussalam

  • Brunei Darussalam
  • Revenue in the Wound Care market is projected to reach US$194.10k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.04%, resulting in a market volume of US$204.40k by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.43 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Brunei Darussalam is experiencing steady growth due to changing customer preferences and increasing demand for wound care products.

Customer preferences:
Customers in Brunei Darussalam are increasingly seeking convenience and accessibility when it comes to purchasing wound care products. As a result, there has been a shift towards purchasing these products from pharmacies, which offer a wide range of options and are easily accessible to the general public. Additionally, customers are becoming more conscious of the quality and effectiveness of wound care products, leading to a growing demand for advanced wound care solutions that promote faster healing and reduce the risk of infection.

Trends in the market:
One of the key trends in the Wound Care (Pharmacies) market in Brunei Darussalam is the increasing adoption of advanced wound care products. These products, such as hydrogels, foam dressings, and alginate dressings, offer superior wound healing properties compared to traditional wound care products. The demand for these advanced products is driven by factors such as the aging population, the prevalence of chronic diseases, and the increasing awareness about the benefits of advanced wound care. Another trend in the market is the growing popularity of wound care products that are made from natural and organic ingredients. Customers in Brunei Darussalam are increasingly seeking products that are gentle on their skin and free from harsh chemicals. This trend is driven by the rising awareness about the potential side effects of certain ingredients found in conventional wound care products. As a result, pharmacies are stocking a wider range of natural and organic wound care products to cater to this demand.

Local special circumstances:
Brunei Darussalam has a small population and a relatively high standard of living. This means that customers in the country have higher disposable incomes and are willing to spend more on healthcare products, including wound care products. Additionally, the government of Brunei Darussalam has been actively promoting healthcare and wellness initiatives, which has further contributed to the growth of the Wound Care (Pharmacies) market in the country.

Underlying macroeconomic factors:
The Wound Care (Pharmacies) market in Brunei Darussalam is also influenced by macroeconomic factors such as population growth, healthcare expenditure, and government policies. The aging population in Brunei Darussalam is increasing, which has led to a higher prevalence of chronic diseases and a greater demand for wound care products. Additionally, the government's focus on healthcare and wellness has resulted in increased healthcare expenditure, which has further fueled the growth of the market. Government policies that promote the use of advanced wound care products and the availability of subsidies for certain healthcare products have also contributed to the growth of the market. In conclusion, the Wound Care (Pharmacies) market in Brunei Darussalam is developing due to changing customer preferences, increasing demand for advanced wound care products, and favorable macroeconomic factors. The market is expected to continue growing as customers seek convenience, quality, and natural ingredients in their wound care products.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)